ft 18 jun 92 technolog wellcom cure despair run drug compani share offer ft writer look aid herp treatment rememb herp earli 1980 herp epidem carri tide sexual promiscu appear sweep west along came aid herp sank public view diseas still incur incid still grow 40 per cent us citizen recurr cold sore caus herp viru genit herp estim 20m us citizen infect paradox herp becom even signific sinc discoveri hiv clinician believ individu lesion caus herp transmit hiv viru easili effect treatment herp may therefor help prevent spread hiv addit aid patient becom highli vulner virus herp famili prove fatal analyst barclay de zoet wedd uk broker estim world market anti herp drug increas dollar 35m pound 19 2m 1981 dollar 1bn last year wellcom lead anti viral drug compani 70 per cent market best sell drug zovirax last year gener sale pound 471m zovirax guanin nucleosid analogu inert non toxic normal cell howev drug enter cell contain herp viru react enzym creat viru becom triphosph convert triphosph interact viru dna structur stop viru replic mechan similar effect azt hiv zovirax cannot elimin herp prevent viru multipli reduc effect length herp attack sinc drug first licens 1981 zovirax use prevent herp recur recent five year studi demonstr patient recurr genit herp treat zovirax seven time less like anoth attack drug also licens herp relat diseas one cytomegaloviru cmv anoth varicella zoster caus chicken pox shingl much sale growth zovirax like come treatment shingl often affect elderli four peopl per 1 000 65 year old contract shingl zovirax receiv us licenc shingl 1991 wellcom start exploit market howev zoster viru less suscept zovirax herp dose need least four time greater bzw estim sale shingl alon worth pound 100m next two year medicin also use transplant patient infect cmv shingl 31 400 peopl receiv transplant us last year number grow 12 15 per cent year transplant patient given immunosuppress prevent immun system reject organ addit effect make patient highli vulner herp relat diseas myron levin univers colorado estim 40 per cent bone marrow patient zoster 75 per cent cmv diseas capabl kill patient hoar govett uk broker estim increas use zovirax herp transplant aid patient allow sale increas pound 471m last year pound 875m 1994 competit zovirax present limit new drug need demonstr safer effect power need less frequent dose smithklin beecham anglo american group develop two compound famcyclovir penciclovir better absorb zovirax work longer meanwhil wellcom develop two compound known 256u87 882u87 recent confer berlin herp clinician told 256 absorb bodi three four time readili zovirax exist treatment drug late clinic trial meanwhil 882 shown highli effect cmv drug earlier clinic trial determin right dose wellcom hope 256 882 market mid 1990 meantim human behaviour demand viral product continu increas unab